Cargando…

Correction to: Neurological manifestations of COVID‑19, SARS and MERS

Detalles Bibliográficos
Autores principales:	Verstrepen, Kato, Baisier, Laure, De Cauwer, Harald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373211/ https://www.ncbi.nlm.nih.gov/pubmed/32696311 http://dx.doi.org/10.1007/s13760-020-01429-9

Ejemplares similares

Neurological manifestations of COVID-19, SARS and MERS
por: Verstrepen, Kato, et al.
Publicado: (2020)

COVID-19, SARS and MERS: A neurological perspective
por: Ng Kee Kwong, Koy Chong, et al.
Publicado: (2020)

Neurological Complications of SARS-CoV, MERS-CoV, and COVID-19
por: Alshebri, Munirah Saad, et al.
Publicado: (2020)

Correction to: Central Nervous System Manifestations Associated with COVID-19
por: Divani, Afshin A., et al.
Publicado: (2020)

Correction to: Virtual visits for chronic neurologic disorders during COVID-19 pandemic
por: Rosellini, Irene, et al.
Publicado: (2021)

Neurological manifestations of post-COVID-19 syndrome S1-guideline of the German society of neurology
por: Franke, Christiana, et al.
Publicado: (2022)

COVID-19 and Neurological Manifestations
por: Forero, Kathleen, et al.
Publicado: (2023)

Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
por: Rockx, Barry, et al.
Publicado: (2020)

Correction: Infection with MERS-CoV Causes Lethal Pneumonia in the Common Marmoset
Publicado: (2014)

Correction: Enhanced Regulatory Sequence Prediction Using Gapped k-mer Features
Publicado: (2014)

Publisher Correction: Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection
por: Patone, Martina, et al.
Publicado: (2021)

Neurological manifestations in COVID‐19 caused by SARS‐CoV‐2
por: Baig, Abdul Mannan
Publicado: (2020)

Correction to: Clinical characteristics of 365 hospitalized COVID-19 patients with neurological symptoms: an observational study
por: Vahabizad, Fahimeh, et al.
Publicado: (2022)

SARS, MERS, and COVID-19: What's next?
por: Sharun, Khan
Publicado: (2020)

A comparison of COVID-19, SARS and MERS
por: Hu, Tingting, et al.
Publicado: (2020)

COVID-19, SARS and MERS: are they closely related?
por: Petrosillo, N., et al.
Publicado: (2020)

Atypical Neurological Manifestations of COVID-19
por: Gupta, Ishita, et al.
Publicado: (2020)

Update on neurological manifestations of COVID-19
por: Yavarpour-Bali, Hanie, et al.
Publicado: (2020)

Neurologic manifestations in an infant with COVID-19
por: Dugue, Rachelle, et al.
Publicado: (2020)

Neurological Manifestations of COVID-19 in Children
por: Lakshan Raj, S., et al.
Publicado: (2021)

COVID-19 Associated Neurological Manifestations
por: Kulkarni, Rahul, et al.
Publicado: (2021)

Neurologic manifestations in children with COVID-19
por: Gürlevik, Sibel Laçinel, et al.
Publicado: (2022)

COVID-19 Associated Neurological Manifestation
por: Mubaraki, Adnan A, et al.
Publicado: (2023)

Are patients with Down syndrome vulnerable to life-threatening COVID-19?
por: De Cauwer, Harald, et al.
Publicado: (2020)

Correction to: Response to letter to the editor, “Neuroradiologic Manifestations of COVID-19: What the Emergency Radiologist Needs to Know”
por: Goldberg, Michael F., et al.
Publicado: (2021)

Author Correction: FQSqueezer: k-mer-based compression of sequencing data
por: Deorowicz, Sebastian
Publicado: (2020)

Author Correction: Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature
por: Korsukewitz, Catharina, et al.
Publicado: (2020)

Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review
por: Ahmed, Muhammad Umer, et al.
Publicado: (2020)

“Neurological manifestations of COVID-19” - guideline of the German society of neurology
por: Berlit, Peter, et al.
Publicado: (2020)

Correction to: Association of body mass index with COVID‑19‑related neurologic sequelae: a retrospective cohort study
por: Elsayed, Sameer, et al.
Publicado: (2023)

Health Care Organizations: Soft Target during COVID-19 Pandemic
por: De Cauwer, Harald G., et al.
Publicado: (2021)

Immune Profiling of COVID-19 in Correlation with SARS and MERS
por: Khalil, Bariaa A., et al.
Publicado: (2022)

The SARS-CoV-2 receptor, ACE-2, is expressed on many different cell types: implications for ACE-inhibitor- and angiotensin II receptor blocker-based cardiovascular therapies: comment
por: De Cauwer, Harald
Publicado: (2020)

Correction: Characterizing the neurological phenotype of the hyperinsulinism hyperammonemia syndrome
por: Rosenfeld, Elizabeth, et al.
Publicado: (2022)

Correction: The Rise of SARS-CoV-2 (COVID-19) Omicron Subvariant Pathogenicity
por: DeGrasse, David C, et al.
Publicado: (2023)

Correction: A Truncated Receptor-Binding Domain of MERS-CoV Spike Protein Potently Inhibits MERS-CoV Infection and Induces Strong Neutralizing Antibody Responses: Implication for Developing Therapeutics and Vaccines
por: Du, Lanying, et al.
Publicado: (2022)

COVID-19 in the nervous system: physiopathology and neurological manifestations
por: Mendonça Filho, Valder Cavalcante Maia, et al.
Publicado: (2023)

Correction: Serological Evidence of MERS-CoV Antibodies in Dromedary Camels (Camelus dromedaries) in Laikipia County, Kenya
Publicado: (2017)

Correction: Oral Manifestations in the American Tegumentary Leishmaniasis
Publicado: (2015)

Lifting the mask on neurological manifestations of COVID-19
por: Pezzini, Alessandro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2cjne8v6b2gbtf55gqlm59qs50